Skip to content

Skin Conditioning

ASIVATREP

Updated
45

Safety score · 0–100

Moderate

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A pharmaceutical TRPV1 antagonist (asivatrep) under study for itch and atopic dermatitis. Drug-grade bioactivity makes it borderline for everyday cosmetic use; treat with caution.

Function

SKIN PROTECTINGSKIN CONDITIONING - MISCELLANEOUS

Skin benefits

  • TRPV1-antagonist for itch/redness
  • Drug candidate for atopic dermatitis
  • Targeted cosmetic actives potential

Known concerns

  • Pharmaceutical-grade molecule, not standard cosmetic
  • Bioactivity at very low %
  • Limited cosmetic safety review

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related skin conditionings

45
ACORUS CALAMUS CALLUS EXTRACELLULAR VESICLES
Skin Conditioning
 45
ADENIUM OBESUM LEAF EXTRACT
Skin Conditioning
 45
ADONIS AMURENSIS EXTRACT
Skin Conditioning
 45
AGERATUM CONYZOIDES LEAF EXTRACT
Skin Conditioning
 45
ANNONA SQUAMOSA SEED EXTRACT
Skin Conditioning
 45
ANTHRISCUS SYLVESTRIS EXTRACT
Skin Conditioning
 45
ARNEBIA NOBILIS ROOT EXTRACT
Skin Conditioning
 45
CAPSICUM ANNUUM RESIN
Skin Conditioning

Check your shelf

Find ASIVATREP in your products.

Scan any cosmetic product with LuxSense to see if it contains ASIVATREP and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.